共 50 条
- [3] A Phase 2 Study Design to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Adults With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S159 - S160
- [4] A phase 2 study investigating the efficacy and safety of dupilumab versus placebo in adults with moderately to severely active ulcerative colitis with an eosinophilic phenotype JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1354 - I1355
- [5] Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (11): : 990 - 1004
- [7] Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (06): : 760 - 768
- [10] Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis in Adolescents and Adults: Results From a Phase 3, Randomized, Placebo-Controlled Trial AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S205 - S206